EPCLUSA 150 MG/37,5 MG GRANULADO RECUBIERTO EN SOBRE
EPCLUSA 150 MG/37,5 MG GRANULADO RECUBIERTO EN SOBRE
Commercialized
Register Number
1161116003
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Jul 27, 2023
Dosage Form
GRANULADO RECUBIERTO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1161116003
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
SOFOSBUVIRActive
Quantity: 150 mg
Name: SOFOSBUVIR
VELPATASVIRActive
Quantity: 37,5 mg
Name: VELPATASVIR
ATC CLASSIFICATION (3)
J05A
J05AP
J05AP55